20
Participants
Start Date
June 1, 2022
Primary Completion Date
December 31, 2022
Study Completion Date
December 31, 2025
Oxaliplatin
"The first and third cycles : transcatheter arterial infusion of oxaliplatin 85mg/m2, day 1.~The second and fourth cycles: intra-venous oxaliplatin 135mg/m2, day 1."
Teysuno
Oral S-1, 40mg-60mg bid, day 1-14 for four 21-day cycles.
Transarterial arterial chemoinfusion and embolism (TACiE)
In the first and third cycles : transcatheter arterial infusion of oxaliplatin 85mg/m2, day 1; transcatheter arterial embolism of tumor feeding arteries, day 1, if applicable.
Shanghai Zhongshan Hospital
OTHER